Advisory Board December 9, 2022
Mark Cuban’s Cost Plus Drug Company (MCCPDC) has partnered with the Purchaser Business Group on Health (PBGH) on a new venture that aims to lower drug costs for self-insured employers—a move that some experts say may be “pulling the rug out from under” legacy pharmacy benefit managers (PBMs).
EmansaRx Plus launches for employers
On Thursday, MCCPDC and PBGH, a coalition of 40 large public and private employers, launched EmansaRx Plus, a subsidiary of PBGH’s PBM EmansaRx. Emansa Rx acts as a supplement to employers’ existing drug benefits and helps beneficiaries find discounts and lower-cost medications.
In a press release, the companies said EmansaRx Plus is “a first-of-its-kind supplemental drug discount product designed specifically for employers.” The new service will offer...
Today's Sponsors
Today's Sponsor